Literature DB >> 6432055

Aldose and aldehyde reductases in human tissues.

S K Srivastava, N H Ansari, G A Hair, B Das.   

Abstract

Immunochemical characterizations of aldose reductase and aldehyde reductases I and II, partially purified by DEAE-cellulose (DE-52) column chromatography from human tissues, were carried out by immunotitration, using antisera raised against the homogenous preparations of human and bovine lens aldose reductase and human placenta aldehyde reductase I and aldehyde reductase II. Anti-aldose antiserum cross-reacted with aldehyde reductase I, anti-aldehyde reductase I antiserum cross-reacted with aldose reductase and anti-aldehyde reductase II antiserum precipitated aldehyde reductase II, but did not cross-react with aldose reductase or aldehyde reductase I from all the tissues examined. DE-52 elution profiles, substrate specificity and immunochemical characterization indicate that aldose reductase is present in human aorta, brain, erythrocyte and muscle; aldehyde reductase I is present in human kidney, liver and placenta; and aldehyde reductase II is present in human brain, erythrocyte, kidney, liver, lung and placenta. Monospecific anti-alpha and anti-beta antisera were purified from placenta anti-aldehyde reductase I antiserum, using immunoaffinity techniques. Anti-alpha antiserum precipitated both aldehyde reductase I and aldose reductase, whereas anti-beta antibodies cross-reacted with only aldehyde reductase I. Based on these studies, a three gene loci model is proposed to explain the genetic interrelationships among these enzymes. Aldose reductase is a monomer of alpha subunits, aldehyde reductase I is a dimer of alpha and beta subunits and aldehyde reductase II is a monomer of delta subunits.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432055     DOI: 10.1016/0304-4165(84)90399-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

2.  Modification of the glyoxalase system in human red blood cells by glucose in vitro.

Authors:  P J Thornalley
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

Review 3.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

4.  Distribution and characterization of dihydrodiol dehydrogenases in mammalian ocular tissues.

Authors:  A Hara; T Nakayama; T Harada; T Kanazu; M Shinoda; Y Deyashiki; H Sawada
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  In vivo and in vitro pharmacokinetics of 4,6-benzylidene-D-glucose (BG) in rats.

Authors:  J M Dornish; R O Larsen; P E Schwarze; B Børretzen; E O Pettersen
Journal:  Invest New Drugs       Date:  1990-05       Impact factor: 3.850

6.  Identification of cardiac oxidoreductase(s) involved in the metabolism of the lipid peroxidation-derived aldehyde-4-hydroxynonenal.

Authors:  S Srivastava; A Chandra; N H Ansari; S K Srivastava; A Bhatnagar
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

7.  Abnormal expression of aldose reductase mRNA in fiber cells of cataractous rat lens. Analysis by in situ hybridization.

Authors:  S Shi; I Bekhor
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

Review 8.  Aldose reductase inhibitors and cataract.

Authors:  M J Crabbe
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

9.  Isolation from pig lens of two proteins with dihydrodiol dehydrogenase and aldehyde reductase activities.

Authors:  A Hara; T Harada; M Nakagawa; K Matsuura; T Nakayama; H Sawada
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

10.  Effect of statil on kidney structure, function and polyol accumulation in diabetes mellitus.

Authors:  G Faiman; P Ganguly; A Mehta; J A Thliveris
Journal:  Mol Cell Biochem       Date:  1993-08-11       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.